DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A better-than-expected third-quarter 2024 performance and a series of favorable coverage ...

A collaboration with Dexcom will go some way to making up ground on the Apple Watch which at this point has over two years’ experience as the smartwatch market leader. Apple has been bulking up ...

In March 2024, a jury found that Dexcom’s G6 glucose monitors infringed one of three of Abbott’s patents, but jurors couldn’t reach a verdict on a fourth patent.

Notably, Dexcom continues to innovate, with a future iteration of its CGM on the way. Sayer described the next-generation ...

Shares of DexCom Inc. DXCM slid 2.58% to $78.92 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.19% to 6,075.11 and ...